Litigation Details for PureWick Corporation v. Sage Products, LLC (D. Del. 2019)
✉ Email this page to a colleague
PureWick Corporation v. Sage Products, LLC (D. Del. 2019)
| Docket | ⤷ Try a Trial | Date Filed | 2019-08-12 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Maryellen Noreika |
| Jury Demand | Plaintiff | Referred To | |
| Patents | 10,029,011; 10,030,051; 10,036,054; 10,041,044; 10,124,014; 10,155,002; 6,031,003; 9,005,016; 9,018,017; 9,023,001; 9,056,059; 9,132,003 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in PureWick Corporation v. Sage Products, LLC
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Biologic Drugs cited in PureWick Corporation v. Sage Products, LLC
The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for PureWick Corporation v. Sage Products, LLC (D. Del. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2021-03-29 | 148 | Redacted Document | 6:27, 6:21-25, 6:40-42, 7:28-56, 8:8-29, 8:38-10:29, 11:1-19, 11:24-36; Washington 508 at Figs. Figs…27, 6:21-25, 6:40- 42, 7:28-56, 8:8-29, 8:38-10:29, 11:1-19, 11:24-36; Parmar 2014 at p. 1; 2015 Omni… 8:38-10:29, 11:24-36; … 8:38-10:29, 11:24-36; …27, 6:21-25, 6:40-42, 7:28- 56, 8:8-29, 8:38-10:29, 11:1-19, 11:24-36; Washington 508 at Figs. 6-9, 2 | External link to document |
| 2021-04-01 | 157 | Redacted Document | counsel that they're not going and 10:30:51 1 additional questions that you think that…and 14 of the ’376 patent, Claim 4 of the ’989 patent, and Claim 10 of the ’407 patent, such that the total…these claims from any of the asserted patents and there is no per-patent limit.” D.I. 87-1 ¶ 1. On November… encompassing three related patent infringement cases involving 23 patents. 686 F. Supp. 2d at 434. Moreover…is “almost identical” to a retained claim? Many patents have claims that, on their face, seem to have narrow | External link to document |
| 2022-03-28 | 308 | Redacted Document | 123:11-18 V, CS, 611 124:1-10 124:14-20 134:19-135:12 147:12-148:…U.S. Patent No. 10,376,407 (“the ’407 patent”) (collectively with the ’508 patent, ’376 patent and ’…infringing U.S. Patent Nos. 8,287,508 (“the ’508 patent) and 10,226,376 (“the ’376 patent). D.I. 1. On … ’989 patent, the “Patents-in-Suit”). D.I. 44. 4. The Patents-in-Suit are directed to external…which the 989 patent issued. 9. U.S. Patent No. 10,226,376 (“the 376 patent”) is entitled | External link to document |
| 2020-08-05 | 72 | - Transcript | 23 10:30:51 1 additional questions that you think that…the asserted patents. So I think that you need to identify 10:40:5120 the patented products that… product, one picture of a product that has a patent on it 10:06:1224 without any date, without… are that are covered by their 10:19:3723 patents-in-suit. 10:19:3924 THE COURT…produce 10:26:5915 documents relating to the patents-in-suit and we haven't 10:27:0416 limited | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
